Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillem Prats

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|October 26, 2019
Evolutionary Trends in RNA Base Selectivity Within the RNase A SuperfamilyGuillem Prats-Ejarque, Lu Lu, Vivian A Salazar, et al.
The Journal of Antimicrobial Chemotherapy|January 5, 2006
Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coliEva Moreno, Guillem Prats, Montserrat Sabaté, et al.
Diagnostic Microbiology and Infectious Disease|September 20, 2005
Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremiaEva Moreno, Irene Planells, Guillem Prats, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 25, 2011
[Microbiological diagnosis of central nervous system infections]María Gema Codina, Marina de Cueto, Diego Vicente, et al.
Infection and Immunity|July 23, 2003
Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreakMaite Muniesa, Mercè de Simon, Guillem Prats, et al.
Emerging Infectious Diseases|September 16, 2003
Community transmission of extended-spectrum beta-lactamaseBeatriz Mirelis, Ferran Navarro, Elisenda Miró, et al.
Research in Microbiology|April 25, 2008
Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewaterMontserrat Sabaté, Guillem Prats, Eva Moreno, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 22, 2006
[Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection]Eva Moreno, Guillem Prats, Irene Planells, et al.
Microbes and Infection|December 27, 2008
Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy womenEva Moreno, James R Johnson, Teresa Pérez, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodElisenda Miró, Ferran Navarro, Beatriz Mirelis, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|October 26, 2019
Evolutionary Trends in RNA Base Selectivity Within the RNase A SuperfamilyGuillem Prats-Ejarque, Lu Lu, Vivian A Salazar, et al.
The Journal of Antimicrobial Chemotherapy|January 5, 2006
Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coliEva Moreno, Guillem Prats, Montserrat Sabaté, et al.
Diagnostic Microbiology and Infectious Disease|September 20, 2005
Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremiaEva Moreno, Irene Planells, Guillem Prats, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 25, 2011
[Microbiological diagnosis of central nervous system infections]María Gema Codina, Marina de Cueto, Diego Vicente, et al.
Infection and Immunity|July 23, 2003
Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreakMaite Muniesa, Mercè de Simon, Guillem Prats, et al.
Emerging Infectious Diseases|September 16, 2003
Community transmission of extended-spectrum beta-lactamaseBeatriz Mirelis, Ferran Navarro, Elisenda Miró, et al.
Research in Microbiology|April 25, 2008
Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewaterMontserrat Sabaté, Guillem Prats, Eva Moreno, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 22, 2006
[Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection]Eva Moreno, Guillem Prats, Irene Planells, et al.
Microbes and Infection|December 27, 2008
Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy womenEva Moreno, James R Johnson, Teresa Pérez, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodElisenda Miró, Ferran Navarro, Beatriz Mirelis, et al.
Pageof 6